Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors.

Clinical genitourinary cancer - 1 Oct 2018

Chahoud Jad, Zhang Miao, Pisters Louis L, Lin Song-Chang, Lin Sue-Hwa, Tu Shi-Ming

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autopsy
Share to Cisplatin
Share to Drug Resistance, Neoplasm
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glypicans

Share to Neoplasms, Germ Cell and Embryonal

Share to Testicular Neoplasms

Share to Up-Regulation

Source

Identifiers

PMID: 29807831
DOI: 10.1016/j.clgc.2018.05.004

Genes

GPC3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors.PMID 29807831Read ↗

Expression of Glypican 3 in Ovarian and Extragonadal Germ Cell TumorsSemantic proximity Read ↗

Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell LinesSemantic proximity Read ↗

Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various PerspectivesSemantic proximity Read ↗

Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver CarcinogenesisSemantic proximity Read ↗

Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumorsSemantic proximity Read ↗

Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathwaySemantic proximity Read ↗

The New Tumour Biomarker miRNA‐371‐3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell LinesSemantic proximity Read ↗

The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other CancersSemantic proximity Read ↗

Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumorsSemantic proximity Read ↗

Expression of glypican 3(GPC3) in embryonal tumorsSemantic proximity Read ↗

Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor PalbociclibSemantic proximity Read ↗

G<sub>4</sub>Mab-9: An Anti-Glypican-4 Monoclonal Antibody for Multiple ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.